HOME >> MEDICINE >> NEWS
Bacterium present in eyes with 'wet' age-related macular degeneration

BOSTON Researchers at the Massachusetts Eye and Ear Infirmary (MEEI) have found that Chlamydia pneumoniae, a bacterium linked to heart disease and capable of causing chronic inflammation, was present in the diseased eye tissue of five out of nine people with neovascular, or "wet," age-related macular degeneration (AMD). However, it was not found in the eyes of more than 20 individuals without AMD, providing more evidence that this disease may be caused by inflammation. The study is described in the November issue of Graefe's Archive for Clinical and Experimental Ophthalmology.

AMD is the leading cause of blindness in Americans over the age of 55. The majority of vision loss is due to neovascular AMD, the advanced form of the disease characterized by the formation of blood vessels in the macula, the center part of the eye's retina. These blood vessels often leak, thus giving neovascular AMD the name of "wet" AMD.

Researchers at the MEEI and Harvard Medical School (HMS) examined nine wet AMD membranes for the presence of C. pneumoniae and also determined whether this pathogen can change the function of eye cells in ways that can cause wet AMD. They found C. pneumoniae in the eyes of five out of the nine patients with wet AMD. They also tested tissue from more than 20 people who did not have AMD and did not find C. pneumoniae in any of these normal eye tissues.

"The paper showed that C. pneumoniae is capable of modifying the function of important cell types involved in regulating normal eye function," said lead author Murat Kalayoglu, MD, PhD. "We found that C. pneumoniae infection led to increased production of vascular endothelial growth factor (VEGF), the key protein involved in wet AMD. That C. pneumoniae infection of human eye cell types increases VEGF production is therefore significant and could explain in part why VEGF levels are increased in many people with wet AMD." Kalayoglu is an HMS research fellow in ophthalmology at MEEI. <
'"/>

Contact: Mary E. Leach
mary_leach@meei.harvard.edu
617-573-4170
Harvard Medical School
7-Nov-2005


Page: 1 2 3

Related medicine news :

1. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
2. Cedars-Sinai researchers present new endocrine findings at 2 international conferences
3. Revlimid data presented at ASCO stands to change the way physicians treat multiple myeloma
4. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
5. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
6. Ulcerative colitis remission rates from long-term safety study of LIALDA presented at DDW
7. NYP/Weill Cornell Urologists present at 2007 AUA Conference
8. Data on new vaccine for prostate cancer to be presented
9. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
10. Epidemiology of TB: Updates from CDC studies to be presented at ATS 2007
11. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/9/2018)... COSTA MESA, Calif. (PRWEB) , ... August 09, ... ... treatment, officially announces LegitScript certification. LegitScript is a new verification process that substance ... Longridge said, “Being LegitScript certified means we can reach more people to help.” ...
(Date:8/9/2018)... ... August 09, 2018 , ... Thanks to the ... company’s independent distributors, customers, and employees, the newly established Isagenix Legacy Foundation ... $2 million goal. 100 percent of the donations will fund grants to nonprofit ...
(Date:8/7/2018)... ... 07, 2018 , ... Today Springfield Creamery added six new ... cream-on-top-style yogurts are made with milk from grass-fed cows who enjoy a diet ... acids. Nancy’s sources the milk from organic family-owned farms, all within 60 miles ...
(Date:8/3/2018)... ... ... On August 2, 2018 the JPML ordered that the Zostavax MDL be ... has been litigating Zostavax injuries since 2011. , On ... the thousands of people injured by Zostavax, a vaccine given to adults to prevent ...
(Date:8/2/2018)... ... 02, 2018 , ... Dr. Srini Pillay , best-selling author of ... people could care less, demonstrating a “whatever” attitude toward life, people, and situations around ... one often overlooked reason relates to being overworked. Called self-regulation depletion (SRD), this condition ...
Breaking Medicine News(10 mins):
(Date:8/9/2018)... (PRWEB) , ... August 09, 2018 , ... ... CBD Day with Charlotte-area company cbdMD named the exclusive sponsor. , “We’re honored ... exciting to see such public embrace for CBD on a national level,” said ...
(Date:8/7/2018)... ... August 07, 2018 , ... Commissioner Gottlieb’s FDA:, Analysis of First ... – 3:00 p.m. ET, http://www.fdanews.com/commissionergottliebsfda , Under Commissioner Scott Gottlieb, changes ... have benefited, some may have gotten hurt. , And Gottlieb is just getting started. ...
(Date:8/7/2018)... PLEASANTON, Calif. (PRWEB) , ... ... ... Chief Executive Officer, today announced the appointment of Richard A. Stark to assume the role of Sanarus ... will apply his 20+ years of strategic development, marketing and sales experience in medical ...
Breaking Medicine Technology:
Cached News: